NCT06975644 2025-05-22
Evaluating Bemotuzumab to Improve the Efficacy of Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer (TNBC)
Zhejiang Provincial People's Hospital
Phase NA Not yet recruiting
Clinical Trials
13 trialsNCT05914753 2023-06-22
Evaluating Xihuang Pill to Improve the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
Zhejiang Provincial People's Hospital
Phase NA Unknown
NCT05656079 2022-12-19
easy laugh
Shanghai Pudong Hospital
Phase NA Unknown
NCT05146635 2022-01-11
Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial
Mansoura University
Phase NA Unknown
NCT05053386 2021-09-22
Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma
Zhejiang Cancer Hospital
Phase NA Unknown
NCT04738188 2021-02-04
Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria;
Beijing Tsinghua Chang Gung Hospital
Phase NA Unknown
NCT03647280 2018-12-07
The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer
Zhejiang Cancer Hospital
Phase NA Unknown
NCT03756090 2018-12-07
PECP
Zhejiang Cancer Hospital
Phase NA Unknown
NCT02358863 2018-09-06
mEGA
Georgetown University
Phase NA Terminated
NCT03022123 2017-01-16
The Study of Pegylated Liposomal Doxorubicin Contrast Epirubicin for the Treatment of Diffuse Large B-cell Lymphoma
Hebei Medical University Fourth Hospital
Phase NA Unknown
NCT01503905 2016-05-24
Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase NA Unknown
NCT00617370 2015-12-23
Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT00146588 2015-03-24
Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer
Dana-Farber Cancer Institute
Phase NA Completed